Meta-Analysis of Risk Stratification of SCN5A With Brugada Syndrome: Is SCN5A Always a Marker of Low Risk?
Background:SCN5A with Brugada syndrome (BrS) is not commonly considered as an independent risk marker for subsequent cardiac events. However, the risk of SCN5A combined with other clinical characteristics has not been fully investigated.Objectives: The aim of this study is to investigate and evaluat...
Main Authors: | Yihan Yang, Dan Hu, Frederic Sacher, Kengo F. Kusano, Xinye Li, Hector Barajas-Martinez, Mélèze Hocini, Yanda Li, Yonghong Gao, Hongcai Shang, Yanwei Xing |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2019-02-01
|
Series: | Frontiers in Physiology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fphys.2019.00103/full |
Similar Items
-
Unique clinical characteristics and SCN5A mutations in patients with Brugada syndrome in Taiwan
by: Jyh-Ming Jimmy Juang, et al.
Published: (2015-07-01) -
H558R, a common SCN5A polymorphism, modifies the clinical phenotype of Brugada syndrome by modulating DNA methylation of SCN5A promoters
by: Hiroya Matsumura, et al.
Published: (2017-12-01) -
In vivo Dominant-Negative Effect of an SCN5A Brugada Syndrome Variant
by: Nicolas Doisne, et al.
Published: (2021-05-01) -
SCN5A gene mutations and the risk of ventricular fibrillation and syncope in Brugada syndrome patients: A meta‐analysis
by: Sunu Budhi Raharjo, et al.
Published: (2018-10-01) -
De Novo Mutation in the SCN5A Gene Associated with Brugada Syndrome
by: Lumin Wang, et al.
Published: (2015-07-01)